A Study of Apatinib Plus Docetaxel for Treatment of Advanced Non-squamous Non-small Cell Lung Cancer With Bone Metastases

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2016
The purpose of this study is to assess the efficacy and safety of patients who receive apatinib plus docetaxel and zoledronic versus docetaxel and zoledronic alone as second line treatment for advanced non‐squamous non‐small cell lung cancer with bone metastases.
Epistemonikos ID: 26f390b89faee0d79c91270416e082fdbc3e4a0c
First added on: May 20, 2024